Natura
November 30, 2022
Natura &Co Holding said in a notice to the market that it is evaluating the potential sale of a minority stake in its Aesop luxury skincare brand, in addition to the IPO and spin-off alternatives it had been studying.
The company said the process is at an early and confidential stage of consultations and that no terms have been defined. The board will decide on the best course after evaluating all alternatives, and an IPO or spin-off remains possible.
Natura &Co announced in October that it was studying a separation of Aesop to fund the brand's accelerated growth and give each of its businesses more autonomy.